• Zum Hauptinhalt springen
  • Zum Footer springen

PSY-PGx

  • About
    • Mission
    • Management & Structure
  • Consortium
  • Research
    • Work Packages
    • Careers
    • Publications
    • Clinical Study
  • Patients
    • Local Websites
    • Clinical Study
  • Media
    • Patient Experiences with Pharmacogenetics
    • Press Releases
    • Patient Inclusion
    • X (formerly Twitter)
  • Internal
  • Events
  • Meet the Team
  • News
  1. PSY-PGx
  2. Research
  3. Work Packages
  4. WP7: Dissemination and Exploitation

WP7: Dissemination and Exploitation 

Lead

Ludwig-Maximilians-Universität München

Institute of Psychiatric Phenomics and Genomics

Dr. Urs Heilbronner

SUNY Upstate Medical University

Department of Psychiatry

Prof. Thomas G. Schulze

Participants/Support

  • Global Alliance of Mental Illness Advocacy Networks
  • World Psychiatric Association
  • Parnassia Groep BV

Goals

  • Raise awareness of PSY-PGx
  • Involve stakeholders throughout the project
  • Communicate, disseminate and exploit the results achieved adhering to Open Science principles

PSY-PGx

A New Intervention for Implementation of Pharmacogenetics in Psychiatry
PSY-PGx Coordinator

Roos van Westrhenen

Psychiatrist & Clinical Pharmacologist (MD, PhD) Parnassia Psychiatric Institute/St. John’s National Academy of Health Sciences, Bangalore, India/King’s College London

Overschiestraat 57
1062 HN Amsterdam, The Netherlands
psqguéicbpziuYiuöcјæeuWä

Sitemap

About
Consortium Members
Research
Patients
News
Internal


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 945151.

Twitter
Editor login
Imprint | Data-Safety